Indian and Chinese drugmakers eye more active expansion into Russian market

Leading Indian and Chinese drugmakers are considering accelerating their expansion into the Russian market – in a move to fill vacant niches that appeared after the reduction of presence of Western pharmaceutical companies in recent months following the invasion of Ukraine.

According to analysts, there is a possibility that Asian drugmakers can not only take the share of Western competitors, but also squeeze out local manufacturers due to the low cost of their drugs.

In the case of India, the country has not only long developed the production of finished dosage forms, but also active ingredients. In addition, Indian generic drug manufacturers obtain licenses from Western companies on better terms than Russian ones, which resulted in lower prices for finished drugs.